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INTRODUCTION 
Nature is mother of mankind. It blesses us through 
various minerals and herbs to live a healthy and wealthy 
long life. Since ancient times, humanity has depended on 
the mixture of the plant and mineral resources for food 
clothing, protection and traditional medicine to cure a 
number of diseases. Arogyavardhini Compound is an 
emerging herbo-mineral formulation of thirteen 
ingredients (Table No.1) formulated for treatment of 
metabolic syndrome.
 1
 In Ayurveda metabolic syndrome  
can be compared with Avaranjanya Madhumeha
2
, which 
is condition of excessive accumulation of Meda (Fatty 
tissues), Kleda and Kapha leading Aavarana 
(Obstruction) of Vata resulting in excretion of Ojasa 
(Essence of body tissues) with urine. Drugs of 
Arogyavardhini Compound like Kajjali (Combination of 
mercury and sulpher) have Yogavahi 
3
( increasing 
potency of formulation and not altering the 
pharmacological action of contents in combinations), 
Tamrabhasma having Lekhan and Sthaulahar 
properties
4
 Abhraka Bhasma have Pramehahar 
property
5
 Lauha Bhasma have Sthaulayahara and 
Rasayana property
6
, Shilajatu and Guggulu have 
Lekhan, Rasayan, Pramehahar properties,
7
 Triphala 
have Pramehahara and Rasayan properties
8
, Katuki 
have Pramehahar, Medahar properties
9
. Lasuna have 
Rasayan and Avaran har properties
 10
. So it can be said 
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that overall effect of formulation may be Lekhan, 
Sthaulyahar, Pramehahar, Avaranhar and Rasayan and 
thus it will be useful in condition of Avaranjanya 
Madhumeha also called as metabolic syndrome.  
There are several components of Arogyavardhini vati 
which are known to have hypolipidemic effects, i.e., 
Picrorrhiza kurroa
11
 Terminalia chebula
12
, Terminalia 
bellerica
13
, Emblica officinalis
14
, and Guggulu
15
. Lasuna 
also possesses anti-hyperlipidemic, anti-diabetic and 
anti-hypertensive activity.
 16
 So the combination of 
Arogyavardhini Rasa and Lasuna may exert significant 
effect on metabolic syndrome.  
Metabolic syndrome is a disorder of energy utilization 
and storage, diagnosed by a co-occurrence of three out 
of five of the following medical conditions: abdominal 
(central) obesity, elevated blood pressure, elevated 
fasting plasma glucose, high serum triglycerides, and 
low high-density cholesterol (HDL) levels. Metabolic 
syndrome increases the risk of developing 
cardiovascular disease, particularly heart failure, and 
diabetes. Some studies have shown the prevalence in the 
USA to be an estimated 34% of the adult population and 
the prevalence increases with age.
 17
 
During the past decades there has been increasing 
acceptance and public interest in natural products and 
therapies in both developing and developed countries. 
So, we cannot assure drug industries insulation from 
adulterations and quality decrement. Therefore, quality 
control for efficacy and safety of herbal products is of 
main concern.
 18, 19
 Maintaining the quality standards of 
the formulation is a challenge. The development of this 
traditional system of medicine with the perspective of 
safety, efficacy and quality will help not only to preserve 
the traditional heritage but also to rationalize the use of 
the natural products in healthcare.
 20, 21
 Initial steps in 
quality standardization of compound formulation is to 
establish the presence of each ingredient in the finished 
product,
 22
 followed by the pharmaceutical analysis. In 
the present study, Arogyavardhini Compound was 
subjected to pharmacognostical (powder microscopy), 
HPTLC, densitogram and pharmaceutical evaluation for 
various physicochemical parameters in order to prepare 
a preliminary profile of formulation for future. 
MATERIAL AND METHODS 
Collection of raw materials:  All the raw drug 
materials were collected from the pharmacy attached 
with institute. The ingredients and parts used of the 
drugs are given in table- 1. 
 
Table 1: Ingredients of Arogyavardhini Compound: 
 
 
 
 
 
 
 
 
 
 
 
 
Pharmacognostical study: Raw drugs were identified 
and authenticated by the Pharmacognosy laboratory. The 
identification was carried out based on organoleptic 
characters of powder (Churna), 
23
 later 
pharmacognostical evaluation of the powder (Churna) 
was carried out. Powder (Churna) was dissolved in 
small quantity of distilled water, filtered through filter 
paper, studied under the Corlzeiss trinocular microscope 
attached with camera, with stain and without stain. The 
microphotographs were also taken under the microscope.
 
24, 25
 
Method of preparation of Arogyavardhini 
Compound: Arogyavardhini rasa was prepared by 
standard method mentioned in Ayurveda. Kajjali (black 
mercury sulphide, Loha bhasma (incinerated iron) 
Abhraka Bhasma (incinerated mica), Tamrabhasma 
(incinerated copper),  Haritaki powder, Bibhitaka 
powder, Amalaki powder, Shuddh Shilajita (Black 
Bitmin), Erandmula, Suddha Guggulu and Katuki 
powder were weighed accurately. First Kajjali and 
Bhasma placed in Khalva and mixed properly, than 
remaining powder added in this mixture and mixed 
thoroughly. Nimbpatra Svarasa was added till the 
mixture immersed completely and trituration was carried 
out till the mixture get semisolid form and dried. Same 
procedure was followed for second Bhavana also.
 26
 
Single bulb Lasuna was collected from green vegetable 
grocer market of local area. Lasuna was first made into 
Content  Latin name  Part used Ratio Form 
Suddha Parada - - 1 part Powder 
Suddha Gandhaka - - 1 part Powder 
Loha Bhasma - - 1 part Bhasma 
Abharaka Bhasma - - 1 part Bhasma 
Tamra Bhasma   - - 1part Bhasma 
Haritaki Terminalia Chebula Linn. Fruit 2  part Churna 
Amalaki Emblica officinalis Linn. Fruit 2  part Churna 
Bibhitaki Terminalia Bellirica Roxb. Fruit 2  part Churna 
Suddha Shilajatu -  3  part Churna 
Suddha Guggulu Commiphora mukul Hook. Gum 4  part Churna 
Eranda Moola Ricinus Communis Linn Root 4 part Churna 
Katuki Picrorhiza Kurrora Roxb. Root/Rhizome 22  part Churna 
Nimba Patra Svarasa Azadirachta Indica A.Juss Leaves Juice Mardana for 2 days 
Single bulb Lasuna  Allium ascalonicum Linn. Bulb 44  part Churna 
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paste and then dried in oven at 60 
0
C temperature for 4-5 
days. 
Dried paste of Lasuna was made into fine powder and 
sieved in mesh no.80. The equal quantity of Lasuna 
powder was mixed well with Arogyavardhini Rasa in 
mass mixing machine till the homogeneous mixture was 
obtained.  
Pharmaceutical evaluation: Arogyavardhini 
Compound was analyzed by using qualitative and 
quantitative parameters at pharmaceutical laboratory. 
The common parameters mentioned for Churna in 
Ayurved pharmacopeia of India and C.C.R.A.S 
guidelines are total Ash value, pH value, water and 
methanol soluble extracts.
27
 On its base the parameters 
were selected. Presence of more moisture contents in a 
sample can create preservative problems of Churna. 
Hence loss on drying was also selected as one of the 
parameter.
 28, 29
 
High performance thin layer chromatography: 
Methanol extract of Arogyavardhini Compound was 
spotted on pre-coated silica gel GF CO254 aluminum 
plate as 5 mm bands, 5 mm apart and 1 cm from the 
edge of the plates, by means of camag, linomate V 
sample applicator fitted with a 100 µL. Hamilton syringe 
was used as the mobile phase. After development, 
densitometry scanning was performed with a camage 
TLC scanner III reflectance absorbance mode at 254 nm 
and 366 nm under control of win CATS software (V 
1.2.1 manufactured by CAMAGE Switzerland).The slit 
dimensions were 6.00 x 0.45 mm and the scanning speed 
was 20 mm per second.
 30
 
OBSERVATIONS AND RESULTS 
The initial purpose of the study was to confirm the 
authenticity of the drugs used in the preparation of 
Arogyavardhini Compound. For this, coarse powder of 
all the ingredients was subjected to organoleptic and 
microscopic evaluation separately to confirm the 
genuineness of all the raw drugs. Later after the 
preparation of formulation, pharmacognostical 
evaluation was carried out.
 
Organoleptic evaluation: Organoleptic features like 
color; odor and taste of the Arogyavardhini Compound 
were recorded and are placed in table no 2.   
Table 2: organoleptic characters of Arogyavardhini 
Compound: 
Parameter Results 
Color Dark grayish 
Odor Like garlic odor 
Test Bitter, astringent 
Consistency Fine course powder 
Microscopic evaluation: Microscopic evaluation was 
conducted by dissolving powder of Arogyavardhini 
Compound in the distilled water and studied under 
microscope for the presence of characteristics of 
ingredient drugs. The diagnostic characters are Scleroids 
of Haritaki (Image:01), Parenchyma cells of Lasuna 
(Image:02),  Rhomboidal crystals of Katukai 
(Image:03), Stone cells with brown contents of Katukai 
(Image:04),  Elongated parenchyma cells of Lasuna 
(Image:05), Stone cells of Haritaki (Image:06), Pitted 
scleroid of Bibhitaka (Image:07), Parenchyma cells with 
prismatic crystals of Lasuna(Image:08),  Parenchyma 
cells with rhomboidal crystals of Katuki(Image:09), 
Spindle shaped fibers of single bulb Lasuna (Image:10),  
Silica deposition of Amalaki (Image:11), Mesocarp cells 
of Amalaki (Image:12), Fragment of annular vessels of 
Lasuna (Image:13), Simple fibers of Amalaki 
(Image:14),  Trichomes of Bibhitaka (Image:15),  
Parenchyma cells and brown contents of Erandmula 
(Image:16), Pitted vessels of Katuki (Image:17), 
Lignified fibers of Erandmula (Image:18)Simple 
trichome of Nimbpatra (Image:19) and Tannin contents 
of Haritaki(Image:20). 
Physico-chemical parameters: Physico-chemical 
parameters of the Churna like loss on drying, pH values 
were found within the normal range. Methanol and water 
soluble extractive values were found to be 17.2% and 
13.5% respectively. Details is shown in table no.3 
 
Table 3: Physico-chemical analysis of Arogyavardhini 
Compound 
Parameter Value 
Loss on drying at 110 
0
C 3.00 % 
Ash Value 13.50% 
Acid insoluble Ash 0.077% 
Water soluble extract 26.72% 
Methanol Soluble extract 14.96% 
pH ( By pH indicator paper) 6.5 
 
High performance thin layer chromatography: 
Densitometry scanning of the HPTLC pattern showed 09 
spots at corresponding Rf values 0.01, 0.03, 0.11, 0.16, 
0.23, 0.28, 0.37, 0.50, 0.88, in short wave UV 254 nm. 
and 07 spots at corresponding Rf values 0.01, 0.03, 0.07, 
0.11, 0.06, 0.24, 0.36, obtained in long wave UV 366 nm 
(Table no.4). Though it cannot be possible to identify 
particular chemical constituent from the spot obtained, 
the pattern may be used as a reference standard for 
further quality control researches. (Images: 21-23) 
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Table 4: Rf Values of Arogyavardhini Compound: 
 Rf Values at 254 nm Rf Values at 366 nm. 
HPTLC 0.01, 0.03, 0.11, 0.16, 0.23, 0.28, 0.37, 0.50, 0.88. 0.01, 0.03, 0.07, 0.11, 0.06, 0.24, 0.36. 
 
 
Figure 1: Pharmacognostical and HPTLC images 
Legends: 
Image: 1- Scleroids of Haritaki   
Image: 2- Parenchyma cells of Lasuna 
Image: 3- Rhomboidal crystals of Katukai  
Image: 4- Stone cells with brown contents of Katukai  
Image: 5- Elongated parenchyma cells of Lasuna 
Image: 6- Stone cells of Haritaki 
Image: 7- Pitted scleroid of Bibhitaka 
Image: 8- Parenchyma cells with prismatic crystals of Lasuna 
Image: 9- Parenchyma cells with rhomboidal crystals of Katuki 
Image: 10- Spindle shaped fibers of single bulb Lasuna 
Image: 11- Silica deposition of Amalaki 
Image: 12- Mesocarp cells of Amalaki 
Image: 13- Fragment of annular vessels of Lasuna 
Image: 14- Simple fibers of Amalaki  
Image: 15- Trichomes of Bibhitaka 
Image: 16- Parenchyma cells and brown contents of Erandmula 
Image: 17- Pitted vessels of Katuki 
Image: 18- Lignified fibers of Erandmula 
Image: 19- Simple trichome of Nimbpatra 
Image: 20- Tannin contents of Haritaki 
Image: 21- Densitogram of methanolic extract of 
Arogyavardhini Compound at 254nm. 
Image: 22- Densitogram of methanolic extract of 
Arogyavardhini Compound at 366nm. 
Image: 23- 3D MWL of methanolic extract of Arogyavardhini 
Compound
 
DISCUSSION 
Powder microscopy of Arogyavardhini Compound 
revealed the diagnostic characters like Scleroids of 
Haritaki, Parenchyma cells of Lasuna,  Rhomboidal 
crystals of Katukai, Stone cells with brown contents of 
Katukai,  Elongated parenchyma cells of Lasuna, Stone 
cells of Haritaki, Pitted scleroid of Bibhitaka, 
Parenchyma cells with prismatic crystals of Lasuna,  
Parenchyma cells with rhomboidal crystals of Katuki, 
Spindle shaped fibers of single bulb Lasuna,  Silica 
deposition of Amalaki, Mesocarp cells of Amalaki, 
Fragment of annular vessels of Lasuna, Simple fibers 
of Amalaki,  Trichomes of Bibhitaka,  Parenchyma 
cells and brown contents of Erandmula, Pitted vessels 
of Katuki, Lignified fibers of Erandmula, Simple 
trichome of Nimbpatra and Tannin contents of Haritaki 
which authenticate genuineness of the raw drugs of 
Arogyavardhini Compound. 
Taste of Arogyavardhini Compound was Tikta (bitter), 
because Katuki is in maximum quantity in 
Arogyavardhini Rasa and having strong bitter taste 
results in bitterness of formulation. Garlic is in equal 
quantity of Arogyavardhini Rasa in this formulation 
may resulted in garlic like odor of formulation. 
Moisture contents should be minimum to prevent 
degradation of product. Excess of water in formulation 
encourage microbial growth, presence of fungi or 
insects and deterioration following hydrolysis. 
Arogyavardhini Compound contains 5.58% w/w 
moisture, showing that tha Churna should be protected 
Padhar et al                                         Journal of Drug Delivery & Therapeutics. 2016; 6(1):46-50 50 
© 2011-15, JDDT. All Rights Reserved                                                   ISSN: 2250-1177                                             CODEN (USA): JDDTAO 
from humid atmosphere. Ash values are the criteria to 
judge the identity and purity of crude drugs were total 
ash, water soluble and acid insoluble ashes are 
considered. Arogyavardhini Compound contained 
15.91% w/w total ash and 0.077% w/w acid insoluble 
ash. The results revealed that Arogyavardhini 
Compound is free from unwanted organic compounds 
and production site was good enough keeping sample 
free from dust and other solid matters. The 13.5% w/w 
of water soluble extractives and 17.2% w/w methanol 
soluble extractives were present in Arogyavardhini 
Compound indicating that the drug is having good 
solubility in water.
[31] 
In HPTLC study 9 spots at 254 nm and 7spots at 366 
nm were obtained, indicating its possible components 
of matrix which may possess its therapeutic effect.      
CONCLUSION 
The ingredients were identified and authenticated 
pharmacognostically and were used for the preparation. 
The formulation was subjected to pharmacognostical 
study reveal genuineness as that all the ingredient 
microscopical characters were observed.  Physico-
chemical and HPTLC studies inferred that the 
formulation meets the minimum quality standards as 
reported in the API at a preliminary level. The 
inference from this study may be used as reference 
standard in the further quality control researches. 
 
REFERENCES 
1. In: Ayurvedic Formulary of India, part-1A, 20/4. 2nd ed. New 
Delhi: Dept. of ISM and H, Ministry of Health and Family 
Welfare, Govt. of India; 2003:58. 
2. Agnivesha, Charaka, Dridhabala, Charaka Samhita, Sutra 
Sthana, KiyantaShirashiyaha Adhyaya, 17/8, edited by 
Yadavaji Trikamji Acharya, 1 
st
 ed. Chaukhambha Surbharathi 
Prakashana, Varanasi, 2011;198. 
3. Ras-tarangini, Taranga 06 / 112, “Rasvigyana commentary” by 
Kashinath Shastri, 11th ed. Delhi: Motilal Banarasidas 
publication; 2009. p. 126.  
4. Ras-tarangini, Taranga 17 / 46, “Rasvigyana commentary” by 
Kashinath Shastri, 11th ed. Delhi: Motilal Banarasidas 
publication; 2009. p. 420.  
5. Ras-tarangini, Taranga 10 / 72, “Rasvigyana commentary” by 
Kashinath Shastri, 11th ed. Delhi: Motilal Banarasidas 
publication; 2009. p. 234.  
6. Ras-tarangini, Taranga 20 / 83, “Rasvigyana commentary” by 
Kashinath Shastri, 11th ed. Delhi: Motilal Banarasidas 
publication; 2009. p. 507.  
7. Ras-tarangini, Taranga 22/ 25, “Rasvigyana commentary” by 
Kashinath Shastri, 11th ed. Delhi: Motilal Banarasidas 
publication; 2009. p. 586.  
8. Bhavamishra, Bhavaprakasha Nighantu, Haritakyadi varga 3 / 
43, commentary by Pandit Brahma Shankar Mishra, 1st ed. 
Varanasi: Chaukhambha Bharati Akademy; 2010. p. 12. 
9. Bhavamishra, Bhavaprakasha Nighantu, Haritakyadi varga 46 / 
152, commentary by Pandit Brahma Shankar Mishra, 1st ed. 
Varanasi: Chaukhambha Bharati Akademy; 2010. p. 67. 
10. Bhavamishra, Bhavaprakasha Nighantu, Haritakyadi varga 77/ 
221-223, commentary by Pandit Brahma Shankar Mishra, 1st 
ed. Varanasi: Chaukhambha Bharati Akademy; 2010. p. 126. 
11. Lee HS, Yoo CB, Ku SK. Hypolipemic effect of water extracts 
of Picrorrhiza kurroa in high fat diet treated mouse. Fitoterapia. 
2006;77:579–84.  
12. Maruthappan V, Shree KS. Hypolipidemic activity of haritaki 
(Terminalia chebula) in atherogenic diet induced 
hyperlipidemic rats. J Adv Pharm Technol Res. 2010;1:229–35.  
13. Saravanan S, Srikumar R, Manikandan S, Jeya Parthasarathy N, 
Sheela Devi R. Hypolipidemic effect of triphala in 
experimentally induced hypercholesteremic rats. Yakugaku 
Zasshi. 2007;127:385–8.  
14. Akhtar MS, Ramzan A, Ali A, Ahmad M. Effect of Amla fruit 
(Emblica officinalis Gaertn) on blood glucose and lipid profile 
of normal subjects and type 2 diabetic patients. Int J Food Sci 
Nutr. 2011;62:609–16.  
15. Nohr LA, Rasmussen LB, Straand J. Resin from the mukul 
myrrh tree, guggul, can it be used for treating 
hypercholesterolemia? A randomized, controlled study. 
Complement Ther Med. 2009;17:16–22.  
16. Peyman M, Surush M, Milad M, Shahin A, Shadi S. 
Therapeutic Uses and Pharmacological Properties of Garlic, 
Shallot, and Their Biologically Active Compounds. Iran J Basic 
Med Sci. 2013 Oct; 16(10): 1031–1048. 
17. http://en.wikipedia.org/wiki/Metabolic_syndrome#cite_note-1 
18. Anonymous. Guidelines on Quality of Herbal Medicinal 
Products/Traditional Medicinal Products, 
EMEA/CVMP/814OO Review, London: European Agency for 
the Evaluation of Medicinal Products (EMEA) publications; 
2005. 
19. Anonymous. The Use of Essential Drugs, Eighth report of the 
WHO Expert committee. Geneva: World Health Organization 
publications; 1990.   
20. Wickramasinghe M, Bandaranayake. Quality control, 
Screening, toxicity, and regulation of herbal drugs. In: Ahmad 
I, Aqil F, Owais M, editors. Modern phytomedicine, turning 
medicinal plants into drugs, Weinheim: WILEY-VCH Verlag 
GmbH & Co. KGaA; 2006. p. 27-57 
21. Mukherjee PK, Wahile A. Integrated approaches towards drug 
development from Ayurveda and other Indian systems of 
medicine. J Ethnopharmacol 2006; 103:25-35.  
22. Satheesh KP, Kumar KV, Menta L, Gopal Rao K, Elsheikh 
Musad MM, Koko Mohamed ME. Standardization of a 
Polyherbal Ayurveda Formulation Nishamalaki Churna Tablet. 
J Pharm Res 2011; 4:1483-7. 
23. Wallis TE. Text Book of Pharmacognosy. 5 th ed. New Delhi: 
CBS Publishers; 1985. p. 571- 
24. Khandelwal KR. Practical Pharmacognosy techniques and 
experiments. 19th ed. Pune:   Nirali Prakashan; 2008. p. 149-66. 
25. Kokate CK, Purohit AP, Gokhale SB. Pharmacognosy. 42 nd 
ed. Pune: Nirali Prakashan; 2008. P.102. 
26. Anonymous, The Ayurvedic Pharmacopoeia of India, Part 2, 
Vol. 1, 1 st ed. New Delhi: Department of AYUSH, Ministry of 
Health and Family welfare, Government of India; 2008. p.140. 
27. Anonymous. Quality control methods for medicinal plant 
materials, Geneva: World    Health Organization; 1998. 
28. Anonymous, Parameters for qualitative assessment of Ayurveda 
and Siddha drugs, Part A, New Delhi: CCRAS; 2005. pp. 31. 
29. Stahl E. A Laboratory hand book. Berlin: Springer-Verlag; 
1969. P.102. 
30. Gupta AK. introduction to pharmaceutics Vol.-1.3rd ed. New 
Delhi: CBS publishers and distribeuters; 1994.p.270. 
 
How to Cite this article: Bharatkumar Chhaganbhai Padhar, 
Preliminary pharmacognostical and phytochemical evaluation of 
arogyavardhini compound- an emerging formulated medicine for 
metabolic syndrome, Journal of Drug Delivery & Therapeutics. 
2016; 6(1) 
 
